Compound details
12-O-acetylphorbol-13-tigliate
| Compound ID | CDAMM01707 |
|---|---|
| Common name | 12-O-acetylphorbol-13-tigliate | IUPAC name | [14-acetyloxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-13-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] 2-methylbut-2-enoate |
| Molecular formula | C27H36O8 |
| Retention time | 6.44 |
|---|---|
| Adduct | [2M+K]+ |
| Actual mz | 1015.44 | Theoretical mz | 1015.45 |
| Error | 9.02 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.8684 |
| Inchi key | XKHUBMMYSWHMHN-ZMIJIPAXSA-N |
|---|---|
| Smiles | O=C(OC12C(OC(=O)C)C(C)C3(O)C(C=C(CO)CC4(O)C(=O)C(=CC43)C)C1C2(C)C)C(=CC)C |
| Superclass | Lipids and lipid-like molecules |
| Class | Prenol lipids |
| HMDB ID | |
|---|---|
| KNApSAcK ID | |
| FooDB ID | |
| DrugBank ID | |
| ChEBI ID | |
| Pubchem Compound ID | 78410838 |
| PlantCyc ID | |
| UNPD ID | UNPD32220 |
| Coconut ID | CNP0236655 |
| LipidMAPS ID | |
| NANPDB ID | NANPDB_2499 |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P29274 | ADORA2A | Adenosine A2a receptor | T77365 | SwissTargetPrediction |
| P35228 | NOS2 | Nitric oxide synthase, inducible | T02703 | SwissTargetPrediction |
| P41594 | GRM5 | Metabotropic glutamate receptor 5 | T99347 | SwissTargetPrediction |
| P43405 | SYK | Tyrosine-protein kinase SYK | T62431 | SwissTargetPrediction |
| P13866 | SLC5A1 | Sodium/glucose cotransporter 1 | T54771 | SwissTargetPrediction |
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SwissTargetPrediction |
| P24864 | CCNE1 | Cyclin-dependent kinase 2/cyclin E1 | T10052 | SwissTargetPrediction |
| Q5T7T8 | COX1 | Prostaglandin G/H synthase 1 | T60529 | SwissTargetPrediction |
| P35354 | PTGS2 | Cyclooxygenase-2 | T66665 | SwissTargetPrediction |
| P10275 | AR | Androgen Receptor | T11211 | SwissTargetPrediction |
| P04183 | TK1 | Thymidine kinase, cytosolic | T30081 | SwissTargetPrediction |
| Q8NER1 | TRPV1 | Vanilloid receptor | T83193 | SwissTargetPrediction |
| P04150 | NR3C1 | Glucocorticoid receptor | T40016 | SwissTargetPrediction |
| P18031 | PTPN1 | Protein-tyrosine phosphatase 1B | T16347 | SwissTargetPrediction |
| P49137 | MAPKAPK2 | MAP kinase-activated protein kinase 2 | T21307 | SwissTargetPrediction |
| P03956 | MMP1 | Matrix metalloproteinase 1 | T52450 | SwissTargetPrediction |
| P08069 | IGF1R | Insulin-like growth factor I receptor | T48069 | SwissTargetPrediction |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SwissTargetPrediction |
| P11309 | PIM1 | Serine/threonine-protein kinase PIM1 | T50594 | SwissTargetPrediction |
| O14757 | CHEK1 | Serine/threonine-protein kinase Chk1 | T62449 | SwissTargetPrediction |
| Q16539 | MAPK14 | MAP kinase p38 alpha | T65864 | SwissTargetPrediction |
| O60674 | JAK2 | Tyrosine-protein kinase JAK2 | T08391 | SwissTargetPrediction |
| P24941 | CDK2 | Cyclin-dependent kinase 2 | T70176 | SwissTargetPrediction |
| P36888 | FLT3 | Tyrosine-protein kinase receptor FLT3 | T74312 | SwissTargetPrediction |
| P11802 | CDK4 | Cyclin-dependent kinase 4 | T85799 | SwissTargetPrediction |
| Q9P1W9 | PIM2 | Serine/threonine-protein kinase PIM2 | T07279 | SwissTargetPrediction |
| Q86V86 | PIM3 | Serine/threonine-protein kinase PIM3 | T16596 | SwissTargetPrediction |
| O14965 | AURKA | Serine/threonine-protein kinase Aurora-A | T87675 | SwissTargetPrediction |
| P78536 | ADAM17 | ADAM17 | T82393 | SwissTargetPrediction |
| Q9Y233 | PDE10A | Phosphodiesterase 10A (by homology) | T84133 | SwissTargetPrediction |
| P62942 | FKBP1A | FK506-binding protein 1A | T76059 | SwissTargetPrediction |
| O14746 | TERT | Telomerase reverse transcriptase | T86052 | SwissTargetPrediction |
| Q08499 | PDE4D | Phosphodiesterase 4D | T02001 | SwissTargetPrediction |
| P49356 | FNTB | Farnesyl protein transferase | T13127 | SwissTargetPrediction |
| P24723 | PRKCH | Protein kinase C eta | T40149 | SwissTargetPrediction |
| Q16850 | CYP51A1 | Cytochrome P450 51 (by homology) | T32972 | SwissTargetPrediction |
| O75116 | ROCK2 | Rho-associated protein kinase 2 | T06093 | SwissTargetPrediction |
| P23458 | JAK1 | Tyrosine-protein kinase JAK1 | T62460 | SwissTargetPrediction |
| P49841 | GSK3B | Glycogen synthase kinase-3 beta | T70977 | SwissTargetPrediction |
| P32246 | CCR1 | C-C chemokine receptor type 1 | T16016 | SwissTargetPrediction |
| P05771 | PRKCB | Protein kinase C beta | T40276 | SwissTargetPrediction |
| Q02156 | PRKCE | Protein kinase C epsilon | T00895 | SwissTargetPrediction and SEA |
| Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | T99057 | SwissTargetPrediction |
| P05362 | ICAM1 | Intercellular adhesion molecule-1 | T26203 | SwissTargetPrediction |
| P16581 | SELE | Selectin E | T72835 | SwissTargetPrediction |
| P10721 | KIT | Stem cell growth factor receptor | T57700 | SwissTargetPrediction |
| Q15078 | CDK5R1 | Cyclin-dependent kinase 5/CDK5 activator 1 | T09513 | SwissTargetPrediction |
| P12931 | SRC | Tyrosine-protein kinase SRC | T85943 | SwissTargetPrediction |
| Q13627 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | T92803 | SwissTargetPrediction |
| P24385 | CCND1 | Cyclin-dependent kinase 4/cyclin D1 | T12355 | SwissTargetPrediction |
| P49759 | CLK1 | Dual specificty protein kinase CLK1 | T46685 | SwissTargetPrediction |
| Q9Y463 | DYRK1B | Dual specificity tyrosine-phosphorylation-regulated kinase 1B | T82720 | SwissTargetPrediction |
| P52333 | JAK3 | Tyrosine-protein kinase JAK3 | T23172 | SwissTargetPrediction |
| Q05655 | PRKCD | Protein kinase C delta | T44861 | SwissTargetPrediction |
| Q9NWZ3 | IRAK4 | Interleukin-1 receptor-associated kinase 4 | T55398 | SwissTargetPrediction |
| P28482 | MAPK1 | MAP kinase ERK2 | T58970 | SwissTargetPrediction |
| P23443 | RPS6KB1 | Ribosomal protein S6 kinase 1 | T94479 | SwissTargetPrediction |
| Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | T98225 | SwissTargetPrediction |
| P09619 | PDGFRB | Platelet-derived growth factor receptor beta | T59102 | SwissTargetPrediction |
| P06493 | CDK1 | Cyclin-dependent kinase 1/cyclin B1 | T49898 | SwissTargetPrediction |
| P07333 | CSF1R | Macrophage colony stimulating factor receptor | T20333 | SwissTargetPrediction |
| P04629 | NTRK1 | Nerve growth factor receptor Trk-A | T07173 | SwissTargetPrediction |
| P49760 | CLK2 | Dual specificity protein kinase CLK2 | T73725 | SwissTargetPrediction |
| P49761 | CLK3 | Dual specificity protein kinase CLK3 | T21585 | SwissTargetPrediction |
| P31639 | SLC5A2 | Sodium/glucose cotransporter 2 | T30085 | SwissTargetPrediction |
| P06737 | PYGL | Liver glycogen phosphorylase | T19184 | SwissTargetPrediction |
| P42574 | CASP3 | Caspase-3 | T57943 | SwissTargetPrediction |
| P55210 | CASP7 | Caspase-7 | T72252 | SwissTargetPrediction |
| P34998 | CRHR1 | Corticotropin releasing factor receptor 1 (by homology) | T45262 | SwissTargetPrediction |
| Q00987 | MDM2 | p53-binding protein Mdm-2 | T00176 | SwissTargetPrediction |
| Q13976 | PRKG1 | cGMP-dependent protein kinase 1 beta | T78543 | SwissTargetPrediction |
| Q04759 | PRKCQ | Protein kinase C theta | T23995 | SwissTargetPrediction |
| P12268 | IMPDH2 | Inosine-5'-monophosphate dehydrogenase 2 | T89360 | SwissTargetPrediction |
| P68400 | CSNK2A1 | Casein kinase II alpha | T51565 | SwissTargetPrediction |
| P19784 | CSNK2A2 | Casein kinase II alpha (prime) | T80526 | SwissTargetPrediction |
| P56373 | P2RX3 | P2X purinoceptor 3 | T17140 | SwissTargetPrediction |
| P46663 | BDKRB1 | Bradykinin B1 receptor | T58589 | SwissTargetPrediction |
| P53609 | PGGT1B | Geranylgeranyl transferase type I | T76396 | SwissTargetPrediction |
| O15151 | MDM4 | Protein Mdm4 | T36741 | SwissTargetPrediction |
| P22001 | KCNA3 | Voltage-gated potassium channel subunit Kv1.3 | T76914 | SwissTargetPrediction |
| P00746 | CFD | Complement factor D | T66383 | SwissTargetPrediction |
| Q9Y5X9 | LIPG | Endothelial lipase | T19368 | SwissTargetPrediction |
| O00408 | PDE2A | Phosphodiesterase 2A | T77400 | SwissTargetPrediction |
| Q92630 | DYRK2 | Dual-specificity tyrosine-phosphorylation regulated kinase 2 | T39486 | SwissTargetPrediction |
| P29401 | TKT | Transketolase | T67754 | SwissTargetPrediction |
| Q00796 | SORD | Sorbitol dehydrogenase | T59445 | SwissTargetPrediction |
| Q06418 | TYRO3 | Tyrosine-protein kinase receptor TYRO3 | T94880 | SwissTargetPrediction |
| P05129 | PRKCG | Protein kinase C gamma | T47107 | SwissTargetPrediction |
| Q9HBA0 | TRPV4 | Transient receptor potential cation channel subfamily V member 4 | T64213 | SwissTargetPrediction |
| P53582 | METAP1 | Methionine aminopeptidase 1 | T42337 | SwissTargetPrediction |
| O00142 | TK2 | Thymidine kinase, mitochondrial | T22976 | SwissTargetPrediction |
| P41252 | IARS | Isoleucyl-tRNA synthetase | T46515 | SwissTargetPrediction |
| Q9H4B7 | TUBB1 | Tubulin beta-1 chain | T84397 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T77365 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P29274 | ADORA2A |
| T77365 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P29274 | ADORA2A |
| T77365 | DI0359 | Radionuclide imaging | [ICD-11: N.A.] | P29274 | ADORA2A |
| T02703 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P35228 | NOS2 |
| T02703 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35228 | NOS2 |
| T02703 | DI0375 | Sepsis | [ICD-11: 1G40-1G41] | P35228 | NOS2 |
| T02703 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35228 | NOS2 |
| T99347 | DI0152 | Fragile X chromosome | [ICD-11: LD55] | P41594 | GRM5 |
| T99347 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P41594 | GRM5 |
| T62431 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P43405 | SYK |
| T54771 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P13866 | SLC5A1 |
| T54771 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P13866 | SLC5A1 |
| T54771 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P13866 | SLC5A1 |
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T60529 | DI0141 | Eye anterior segment structural developmental anomaly | [ICD-11: LA11] | Q5T7T8 | COX1 |
| T60529 | DI0145 | Female pelvic pain | [ICD-11: GA34] | Q5T7T8 | COX1 |
| T60529 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q5T7T8 | COX1 |
| T60529 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | Q5T7T8 | COX1 |
| T60529 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | Q5T7T8 | COX1 |
| T60529 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q5T7T8 | COX1 |
| T60529 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q5T7T8 | COX1 |
| T60529 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q5T7T8 | COX1 |
| T60529 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q5T7T8 | COX1 |
| T60529 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | Q5T7T8 | COX1 |
| T60529 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | Q5T7T8 | COX1 |
| T60529 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | Q5T7T8 | COX1 |
| T66665 | DI0087 | Chronic pain | [ICD-11: MG30] | P35354 | PTGS2 |
| T66665 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P35354 | PTGS2 |
| T66665 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P35354 | PTGS2 |
| T66665 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P35354 | PTGS2 |
| T66665 | DI0227 | Knee osteoarthritis | [ICD-11: FA01] | P35354 | PTGS2 |
| T66665 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35354 | PTGS2 |
| T66665 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35354 | PTGS2 |
| T66665 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P35354 | PTGS2 |
| T66665 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | P35354 | PTGS2 |
| T11211 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P10275 | AR |
| T11211 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10275 | AR |
| T11211 | DI0021 | Alcoholic liver disease | [ICD-11: DB94] | P10275 | AR |
| T11211 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P10275 | AR |
| T11211 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P10275 | AR |
| T11211 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P10275 | AR |
| T11211 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P10275 | AR |
| T11211 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | P10275 | AR |
| T11211 | DI0247 | Mammary tumour | [ICD-11: 2C60-2C6Z] | P10275 | AR |
| T11211 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P10275 | AR |
| T11211 | DI0401 | Testicular dysfunction | [ICD-11: 5A81] | P10275 | AR |
| T30081 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P04183 | TK1 |
| T30081 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P04183 | TK1 |
| T83193 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q8NER1 | TRPV1 |
| T40016 | DI0016 | Adaptive immunity immunodeficiency | [ICD-11: 4A01] | P04150 | NR3C1 |
| T40016 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P04150 | NR3C1 |
| T40016 | DI0037 | Asthma | [ICD-11: CA23] | P04150 | NR3C1 |
| T40016 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P04150 | NR3C1 |
| T40016 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P04150 | NR3C1 |
| T40016 | DI0280 | Muscular dystrophy | [ICD-11: 8C70] | P04150 | NR3C1 |
| T40016 | DI0314 | Oesophagitis | [ICD-11: DA24] | P04150 | NR3C1 |
| T40016 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P04150 | NR3C1 |
| T40016 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P04150 | NR3C1 |
| T40016 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04150 | NR3C1 |
| T40016 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | P04150 | NR3C1 |
| T16347 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P18031 | PTPN1 |
| T16347 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P18031 | PTPN1 |
| T16347 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18031 | PTPN1 |
| T16347 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P18031 | PTPN1 |
| T21307 | DI0011 | Acute laryngitis/tracheitis | [ICD-11: CA05] | P49137 | MAPKAPK2 |
| T21307 | DI0181 | Hidradenitis suppurativa | [ICD-11: ED92] | P49137 | MAPKAPK2 |
| T21307 | DI0269 | Monogenic autoinflammatory syndrome | [ICD-11: 4A60] | P49137 | MAPKAPK2 |
| T21307 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P49137 | MAPKAPK2 |
| T21307 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P49137 | MAPKAPK2 |
| T21307 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P49137 | MAPKAPK2 |
| T21307 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P49137 | MAPKAPK2 |
| T52450 | DI0238 | Lung cancer | [ICD-11: 2C25] | P03956 | MMP1 |
| T48069 | DI0276 | Multiple structural anomalies syndrome | [ICD-11: LD2F] | P08069 | IGF1R |
| T48069 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P08069 | IGF1R |
| T48069 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P08069 | IGF1R |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T50594 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11309 | PIM1 |
| T50594 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11309 | PIM1 |
| T62449 | DI0027 | Anal cancer | [ICD-11: 2C00] | O14757 | CHEK1 |
| T62449 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | O14757 | CHEK1 |
| T62449 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | O14757 | CHEK1 |
| T62449 | DI0238 | Lung cancer | [ICD-11: 2C25] | O14757 | CHEK1 |
| T62449 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O14757 | CHEK1 |
| T62449 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O14757 | CHEK1 |
| T62449 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14757 | CHEK1 |
| T62449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14757 | CHEK1 |
| T65864 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q16539 | MAPK14 |
| T65864 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q16539 | MAPK14 |
| T65864 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q16539 | MAPK14 |
| T65864 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | Q16539 | MAPK14 |
| T08391 | DI0039 | Atopic eczema | [ICD-11: EA80] | O60674 | JAK2 |
| T08391 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | O60674 | JAK2 |
| T08391 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | O60674 | JAK2 |
| T08391 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | O60674 | JAK2 |
| T70176 | DI0060 | Brain cancer | [ICD-11: 2A00] | P24941 | CDK2 |
| T70176 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P24941 | CDK2 |
| T70176 | DI0238 | Lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P24941 | CDK2 |
| T70176 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P24941 | CDK2 |
| T70176 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P24941 | CDK2 |
| T70176 | DI0406 | Thymoma | [ICD-11: 2C27] | P24941 | CDK2 |
| T74312 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P36888 | FLT3 |
| T74312 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P36888 | FLT3 |
| T74312 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P36888 | FLT3 |
| T74312 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P36888 | FLT3 |
| T74312 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P36888 | FLT3 |
| T74312 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P36888 | FLT3 |
| T74312 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P36888 | FLT3 |
| T74312 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P36888 | FLT3 |
| T85799 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11802 | CDK4 |
| T85799 | DI0238 | Lung cancer | [ICD-11: 2C25] | P11802 | CDK4 |
| T85799 | DI0351 | Psoriasis | [ICD-11: EA90] | P11802 | CDK4 |
| T07279 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9P1W9 | PIM2 |
| T07279 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9P1W9 | PIM2 |
| T87675 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | O14965 | AURKA |
| T87675 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14965 | AURKA |
| T82393 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P78536 | ADAM17 |
| T82393 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P78536 | ADAM17 |
| T84133 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q9Y233 | PDE10A |
| T84133 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q9Y233 | PDE10A |
| T84133 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9Y233 | PDE10A |
| T84133 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q9Y233 | PDE10A |
| T84133 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9Y233 | PDE10A |
| T76059 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P62942 | FKBP1A |
| T76059 | DI0349 | Pruritus | [ICD-11: EC90] | P62942 | FKBP1A |
| T76059 | DI0413 | Transplant rejection | [ICD-11: NE84] | P62942 | FKBP1A |
| T86052 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | O14746 | TERT |
| T86052 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O14746 | TERT |
| T86052 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14746 | TERT |
| T02001 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | Q08499 | PDE4D |
| T13127 | DI0342 | Premature ageing appearance | [ICD-11: LD2B] | P49356 | FNTB |
| T40149 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P24723 | PRKCH |
| T32972 | DI0209 | Infectious meningitis | [ICD-11: 1D01] | Q16850 | CYP51A1 |
| T32972 | DI0289 | Nail/perionychium infection | [ICD-11: EE12] | Q16850 | CYP51A1 |
| T32972 | DI0316 | Onchocerciasis | [ICD-11: 1F6A] | Q16850 | CYP51A1 |
| T06093 | DI0168 | Graft-versus-host disease | [ICD-11: 4B24] | O75116 | ROCK2 |
| T62460 | DI0039 | Atopic eczema | [ICD-11: EA80] | P23458 | JAK1 |
| T62460 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P23458 | JAK1 |
| T62460 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P23458 | JAK1 |
| T62460 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | P23458 | JAK1 |
| T70977 | DI0288 | Myotonic disorder | [ICD-11: 8C71] | P49841 | GSK3B |
| T16016 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P32246 | CCR1 |
| T16016 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P32246 | CCR1 |
| T40276 | DI0123 | Diffuse large B-cell lymphoma | [ICD-11: 2A81] | P05771 | PRKCB |
| T40276 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P05771 | PRKCB |
| T40276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P05771 | PRKCB |
| T00895 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | Q02156 | PRKCE |
| T00895 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | Q02156 | PRKCE |
| T99057 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | Q02750 | MAP2K1 |
| T99057 | DI0336 | Phakomatoses/hamartoneoplastic syndrome | [ICD-11: LD2D] | Q02750 | MAP2K1 |
| T26203 | DI0436 | Visual system disease | [ICD-11: 9E1Z] | P05362 | ICAM1 |
| T72835 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P16581 | SELE |
| T72835 | DI0037 | Asthma | [ICD-11: CA23] | P16581 | SELE |
| T72835 | DI0039 | Atopic eczema | [ICD-11: EA80] | P16581 | SELE |
| T72835 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P16581 | SELE |
| T72835 | DI0088 | Circulatory system disease | [ICD-11: BE2Z] | P16581 | SELE |
| T72835 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P16581 | SELE |
| T72835 | DI0351 | Psoriasis | [ICD-11: EA90] | P16581 | SELE |
| T57700 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P10721 | KIT |
| T57700 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P10721 | KIT |
| T57700 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P10721 | KIT |
| T57700 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P10721 | KIT |
| T57700 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P10721 | KIT |
| T57700 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P10721 | KIT |
| T57700 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P10721 | KIT |
| T85943 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P12931 | SRC |
| T85943 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P12931 | SRC |
| T85943 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P12931 | SRC |
| T85943 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P12931 | SRC |
| T92803 | DI0113 | Cytomegaloviral disease | [ICD-11: 1D82] | Q13627 | DYRK1A |
| T12355 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P24385 | CCND1 |
| T23172 | DI0023 | Alopecia | [ICD-11: ED70] | P52333 | JAK3 |
| T23172 | DI0039 | Atopic eczema | [ICD-11: EA80] | P52333 | JAK3 |
| T23172 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P52333 | JAK3 |
| T23172 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P52333 | JAK3 |
| T44861 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q05655 | PRKCD |
| T55398 | DI0039 | Atopic eczema | [ICD-11: EA80] | Q9NWZ3 | IRAK4 |
| T55398 | DI0109 | Cutaneous lupus erythematosus | [ICD-11: EB50-EB5Z] | Q9NWZ3 | IRAK4 |
| T55398 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q9NWZ3 | IRAK4 |
| T55398 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q9NWZ3 | IRAK4 |
| T55398 | DI0351 | Psoriasis | [ICD-11: EA90] | Q9NWZ3 | IRAK4 |
| T55398 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9NWZ3 | IRAK4 |
| T58970 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P28482 | MAPK1 |
| T58970 | DI0252 | Melanoma | [ICD-11: 2C30] | P28482 | MAPK1 |
| T58970 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P28482 | MAPK1 |
| T58970 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P28482 | MAPK1 |
| T94479 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P23443 | RPS6KB1 |
| T94479 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P23443 | RPS6KB1 |
| T94479 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P23443 | RPS6KB1 |
| T59102 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P09619 | PDGFRB |
| T59102 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P09619 | PDGFRB |
| T59102 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P09619 | PDGFRB |
| T49898 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06493 | CDK1 |
| T49898 | DI0238 | Lung cancer | [ICD-11: 2C25] | P06493 | CDK1 |
| T49898 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P06493 | CDK1 |
| T49898 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P06493 | CDK1 |
| T49898 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06493 | CDK1 |
| T20333 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P07333 | CSF1R |
| T07173 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P04629 | NTRK1 |
| T07173 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04629 | NTRK1 |
| T30085 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P31639 | SLC5A2 |
| T30085 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P31639 | SLC5A2 |
| T30085 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P31639 | SLC5A2 |
| T57943 | DI0060 | Brain cancer | [ICD-11: 2A00] | P42574 | CASP3 |
| T72252 | DI0110 | Cystic fibrosis | [ICD-11: CA25] | P55210 | CASP7 |
| T45262 | DI0394 | Staphylococcal/streptococcal disease | [ICD-11: 1B5Y] | P34998 | CRHR1 |
| T00176 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q00987 | MDM2 |
| T00176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q00987 | MDM2 |
| T23995 | DI0413 | Transplant rejection | [ICD-11: NE84] | Q04759 | PRKCQ |
| T89360 | DI0413 | Transplant rejection | [ICD-11: NE84] | P12268 | IMPDH2 |
| T51565 | DI0104 | Coronavirus infection | [ICD-11: 1D92] | P68400 | CSNK2A1 |
| T51565 | DI0235 | Liver cancer | [ICD-11: 2C12] | P68400 | CSNK2A1 |
| T51565 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P68400 | CSNK2A1 |
| T17140 | DI0105 | Cough | [ICD-11: MD12] | P56373 | P2RX3 |
| T58589 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P46663 | BDKRB1 |
| T58589 | DI0365 | Retinopathy | [ICD-11: 9B71] | P46663 | BDKRB1 |
| T58589 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P46663 | BDKRB1 |
| T76396 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P53609 | PGGT1B |
| T36741 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | O15151 | MDM4 |
| T36741 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O15151 | MDM4 |
| T36741 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O15151 | MDM4 |
| T36741 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O15151 | MDM4 |
| T76914 | DI0198 | Idiopathic inflammatory myopathy | [ICD-11: 4A41] | P22001 | KCNA3 |
| T76914 | DI0351 | Psoriasis | [ICD-11: EA90] | P22001 | KCNA3 |
| T76914 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P22001 | KCNA3 |
| T66383 | DI0170 | Haemolytic anemia | [ICD-11: 3A20-3A2Z] | P00746 | CFD |
| T66383 | DI0365 | Retinopathy | [ICD-11: 9B71] | P00746 | CFD |
| T19368 | DI0081 | Chronic arterial occlusive disease | [ICD-11: BD4Z] | Q9Y5X9 | LIPG |
| T19368 | DI0091 | Coagulation defect | [ICD-11: 3B10] | Q9Y5X9 | LIPG |
| T19368 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q9Y5X9 | LIPG |
| T77400 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | O00408 | PDE2A |
| T77400 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | O00408 | PDE2A |
| T77400 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | O00408 | PDE2A |
| T77400 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | O00408 | PDE2A |
| T94880 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q06418 | TYRO3 |
| T47107 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P05129 | PRKCG |
| T47107 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P05129 | PRKCG |
| T64213 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q9HBA0 | TRPV4 |
| T64213 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q9HBA0 | TRPV4 |
| T64213 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | Q9HBA0 | TRPV4 |
| T22976 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | O00142 | TK2 |
| T84397 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9H4B7 | TUBB1 |